Clinical trial NCT02058927 - References

Measles — Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Citation(s)

•   Angel JB, Walpita P, Lerch RA, Sidhu MS, Masurekar M, DeLellis RA, Noble JT, Snydman DR, Udem SA
  Vaccine-associated measles pneumonitis in an adult with AIDS. Ann Intern Med. 1998 Jul 15;129(2):104-6.
•   Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J
  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997 Jul 4;277(5322):112-6.
•   Berkelhamer S, Borock E, Elsen C, Englund J, Johnson D
  Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children. Clin Infect Dis. 2001 Apr 1;32(7):1090-4. Epub 2001 Mar 19.
•   Bernasconi NL, Traggiai E, Lanzavecchia A
  Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002 Dec 13;298(5601):2199-202.
•   Burgess K, Price P, James IR, Stone SF, Keane NM, Lim AY, Warmington JR, French MA
  Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART. J Clin Immunol. 2006 Mar;26(2):160-7. Epub 2006 Mar 28.
•   Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN
  Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature. 2006 Apr 13;440(7086):890-5.
•   Chavan S, Bennuri B, Kharbanda M, Chandrasekaran A, Bakshi S, Pahwa S
  Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus. J Infect Dis. 2001 May 15;183(10):1445-54. Epub 2001 Apr 13.
•   Crotty S, Ahmed R
  Immunological memory in humans. Semin Immunol. 2004 Jun;16(3):197-203. Review.
•   Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R
  SAP is required for generating long-term humoral immunity. Nature. 2003 Jan 16;421(6920):282-7.
•   de Martino M, Tovo PA, Balducci M, Galli L, Gabiano C, Rezza G, Pezzotti P
  Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000 Jul 12;284(2):190-7.
•   De Milito A, Mörch C, Sönnerborg A, Chiodi F
  Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS. 2001 May 25;15(8):957-64.
•   De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, Grutzmeier S, Sönnerborg A, Chiodi F
  Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood. 2004 Mar 15;103(6):2180-6. Epub 2003 Nov 6.
•   De Rossi A, Walker AS, Klein N, De Forni D, King D, Gibb DM
  Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. J Infect Dis. 2002 Aug 1;186(3):312-20. Epub 2002 Jul 5.
•   Douek DC, Koup RA, McFarland RD, Sullivan JL, Luzuriaga K
  Effect of HIV on thymic function before and after antiretroviral therapy in children. J Infect Dis. 2000 Apr;181(4):1479-82. Epub 2000 Apr 13.
•   Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM
  Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis. 2001 Oct 1;184(7):817-26. Epub 2001 Aug 22.
•   Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Woerner I, Babiker A
  Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee. Lancet. 2000 Apr 15;355(9212):1331-2.
•   Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR 3rd, Song LY, Dankner WM, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team
  Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001 Nov 22;345(21):1522-8.
•   Hainaut M, Ducarme M, Schandene L, Peltier CA, Marissens D, Zissis G, Mascart F, Levy J
  Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 2003 Jan;22(1):62-9.
•   Hebeis BJ, Klenovsek K, Rohwer P, Ritter U, Schneider A, Mach M, Winkler TH
  Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med. 2004 Feb 16;199(4):593-602. Epub 2004 Feb 9.
•   Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP
  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature. 2003 Feb 20;421(6925):852-6. Epub 2003 Feb 9.
•   Johnston AM, Valentine ME, Ottinger J, Baydo R, Gryszowka V, Vavro C, Weinhold K, St Clair M, McKinney RE
  Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study. Pediatr Infect Dis J. 2001 Oct;20(10):941-6.
•   Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R
  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003 Dec;4(12):1191-8. Epub 2003 Nov 16.
•   Lanzavecchia A, Sallusto F
  Understanding the generation and function of memory T cell subsets. Curr Opin Immunol. 2005 Jun;17(3):326-32. Review.
•   Madakamutil LT, Christen U, Lena CJ, Wang-Zhu Y, Attinger A, Sundarrajan M, Ellmeier W, von Herrath MG, Jensen P, Littman DR, Cheroutre H
  CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors. Science. 2004 Apr 23;304(5670):590-3.
•   Malaspina A, Moir S, Orsega SM, Vasquez J, Miller NJ, Donoghue ET, Kottilil S, Gezmu M, Follmann D, Vodeiko GM, Levandowski RA, Mican JM, Fauci AS
  Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis. 2005 May 1;191(9):1442-50. Epub 2005 Mar 24.
•   McHeyzer-Williams LJ, McHeyzer-Williams MG
  Antigen-specific memory B cell development. Annu Rev Immunol. 2005;23:487-513. Review.
•   Melvin AJ, Mohan KM
  Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. Pediatrics. 2003 Jun;111(6 Pt 1):e641-4.
•   Moss WJ, Clements CJ, Halsey NA
  Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ. 2003;81(1):61-70. Epub 2003 Mar 11. Review.
•   Moss WJ, Cutts F, Griffin DE
  Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis. 1999 Jul;29(1):106-12.
•   Nanan R, Rauch A, Kämpgen E, Niewiesk S, Kreth HW
  A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol. 2000 May;81(Pt 5):1313-9.
•   Newell ML, Brahmbhatt H, Ghys PD
  Child mortality and HIV infection in Africa: a review. AIDS. 2004 Jun;18 Suppl 2:S27-34. Review.
•   Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA, Poland GA
  Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol. 2003 May;10(3):411-6.
•   Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, Schellekens PT
  Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998 Feb;4(2):208-14.
•   Resino S, Correa R, Bellón JM, Sánchez-Ramón S, Muñoz-Fernández MA
  Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS. AIDS Res Hum Retroviruses. 2002 Dec 10;18(18):1395-406.
•   Shedlock DJ, Shen H
  Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003 Apr 11;300(5617):337-9.
•   Slifka MK
  Immunological memory to viral infection. Curr Opin Immunol. 2004 Aug;16(4):443-50. Review.
•   Sun JC, Bevan MJ
  Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003 Apr 11;300(5617):339-42.
•   Sun JC, Williams MA, Bevan MJ
  CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol. 2004 Sep;5(9):927-33. Epub 2004 Aug 8.
•   van Els CA, Nanan R
  T cell responses in acute measles. Viral Immunol. 2002;15(3):435-50. Review.
•   van Rossum AM, Scherpbier HJ, van Lochem EG, Pakker NG, Slieker WA, Wolthers KC, Roos MT, Kuijpers JH, Hooijkaas H, Hartwig NG, Geelen SP, Wolfs TF, Lange JM, Miedema F, de Groot R; Dutch Study Group for Children with HIV Infections
  Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status. AIDS. 2001 Nov 23;15(17):2267-75.
•   Vieira P, Rajewsky K
  Persistence of memory B cells in mice deprived of T cell help. Int Immunol. 1990;2(6):487-94.
•   Vigano A, Vella S, Saresella M, Vanzulli A, Bricalli D, Di Fabio S, Ferrante P, Andreotti M, Pirillo M, Dally LG, Clerici M, Principi N
  Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS. 2000 Feb 18;14(3):251-61.
•   Weinberg A, Gona P, Nachman SA, Defechereux P, Yogev R, Hughes W, Wara D, Spector SA, Read J, Elgie C, Cooper M, Dankner W; Pediatric AIDS Clinical Trials Group 1008 Team
  Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy. J Infect Dis. 2006 Jan 15;193(2):302-11. Epub 2005 Dec 7.
•   Weinberg A, Pahwa S, Oyomopito R, Carey VJ, Zimmer B, Mofenson L, Kovacs A, Burchett SK; Pediatric AIDS Clinical Trials Group 366 Team
  Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2004 Jul 1;39(1):107-14. Epub 2004 Jun 14.
•   Weinberg A, Wiznia AA, LaFleur BJ, Shah S, Levin MJ
  Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis. 2004 Jul 15;190(2):267-70. Epub 2004 Jun 9.

Immune Reconstitution to Measles Virus of HIV-1-Infected Zambian Children Initiating Antiretroviral Therapy

Details for clinical trial NCT02058927